Clinical Trials, Inc.

CTI is proud to host a clinical trial for diabetic peripheral neuropathy drug "REGAiN-1A". See our interview with KATV at
https://katv.com/community/good-morning-arkansas/diabetic-neuropathy-drug-study-with-clinical-trials-inc

Diabetic Neuropathy drug study with Clinical Trials, Inc CLICK HERE for more information.

~ November is Alzheimer's Awareness month ~

Have a safe and happy Halloween from all of us at CTI!

This is exciting news!

Alzheimer's: Biogen to ask FDA to approve Aducanumab as first treatment for early stage of disease Clinical trials for the drug were discontinued earlier this year, sending shockwaves through the industry.

Depression is common with conditions like epilepsy, stroke, and Parkinson's disease. Learn how to identify and deal with this mood disorder.

Neurologic Conditions Can Lead to Depression—Here’s How to Manage It Depression is common with neurologic conditions like epilepsy, stroke, and Parkinson's disease. Learn how to identify and manage this mood disorder.

This is exciting! Hope the human trials are successful!

Alzheimer’s Vaccine to Cut Cases in Half The vaccine has already seen success in mice, rabbits, and monkeys.

Navigating Cognitive Changes in Parkinson’s Disease
Attention - Memory - Executive Function - Language - Visuospatial skills

https://www.michaeljfox.org/sites/default/files/media/document/MJFF_cognition-guide_digital.pdf?em_cid=mc-a1b1R000008MpRi&et_cid=1403949&et_rid=380921272&et_lid=Navigating+Cognitive+Changes+in+Parkinson%26amp%3b%23x27%3bs&em_cid=

We currently have a study for PD patients with cognitive decline. Contact us for more information 501-227-6179. [email protected]

"Every time there's a failure it's absolutely clear that we learn a lot," Emory University neurologist Dr. Allan Levey

Scientists rethink Alzheimer's, diversifying the drug search


We currently have a trial for Alzheimer's patients with agitation. Contact us for more information 501-227-6179.
[email protected]

Scientists rethink Alzheimer's, diversifying the drug search When researchers at the University of Kentucky compare brains donated from people who died with dementia, very rarely do they find one that bears only Alzheimer's trademark plaques and tangles — no other damage. If they do, "we call it a unicorn," said Donna Wilcock, an Alzheimer's

Hope everyone had a safe and Happy Labor Day!

Alzheimer’s Vaccine to Cut Cases in Half The vaccine has already seen success in mice, rabbits, and monkeys.

Early stages, but still promising!

A Small Proof of Concept Study Finds a “Rescue Inhaler”... : Neurology Today An abstract is unavailable.

On July 11, bestselling author Kurt Eichenwald led an inspiring discussion about Epilepsy and his Memoir, ‘A Mind Unraveled’ with our sites in Miami and members of Epilepsy Florida. The Memoir is an inspiring story about perseverance and fortitude in overcoming the paralyzing fear of seizures and extreme helplessness people with epilepsy live with every day.
https://vimeo.com/349086181

Kurt Eichenwald Author Kurt Eichenwald discusses the promise of Staccato Alprazolam

Sign up today!
"Every clinical trial needs volunteers.
Fox Trial Finder knows which trials need you."
https://foxtrialfinder.michaeljfox.org/

FOX TRIAL FINDER : Parkinson's Disease Clinical Trials Fox Trial Finder is a user friendly matching tool that connects volunteers with the PD clinical trials that need them.

Call or email our office for more information
📞501-227-6179
🖱[email protected]

Wishing everyone a happy and safe Memorial Day weekend!

9 Things To Do ASAP When You Find Out You Have Alzheimer’s Being informed and proactive now is a smart way to manage fear and stress about the future.

UCLA study suggests vitamin D may be a safe, seizure-minimizing epilepsy treatment Vitamin D may help reduce the frequency of seizures in epilepsy patients, according to a recent study from UCLA.Researchers in the lab of Christopher DeGiorgio, a professor of neurology, found…

Alzheimer's Team

Another reason it is so hard to find treatments and/or a cure. If we can’t clearly diagnose, how do we solve the problem? Research is our BEST tool for both issues.

Doctors have recently named a new form of dementia. This form is known as limbic-predominant age-related TDP-43 encephalopathy, or LATE.

LATE often mirrors the symptoms of Alzheimer's disease, though it affects the brain differently and develops more slowly than Alzheimer's. The two conditions are frequently found together.

A recent article from CNN gives further details regarding this condition.

Read more:
https://cnn.it/2UTkivo

We have done several studies on investigational drugs hoping to diminish the amyloid plaques in the brain. Lab studies are showing THC helps with reducing plaques and inflammation.
Thoughts?

Compound Found in Ma*****na Is Capable of Breaking Down Alzheimer’s-Causing Plaques But will legal restrictions get in the way of clinical trials and making this treatment available to the public?

Brain ‘Pacemaker’ Shows Promise in Slowing Decline of Alzheimer’s Could this lead to the cure we've been waiting for?

🧐You can always check our website for current studies - www.clinicaltrialsinc.com

We have 3 , 1 and several for . Call or email for more information!
[email protected]
501-227-6179

Clinical Trials Inc. – Hope Through Research Our multidisciplinary research facility has been specializing in providing Hope Through Research to Arkansas patients for over 30 years. Our medical team is experienced in providing quality clinical studies, superior patient care, and the use of cutting-edge modern methods. Contact us today, and fin...

Subtle Symptoms of MS You Should Never Ignore MS is an autoimmune disease that affects the central nervous system.

We will be there with information about our current Parkinson's studies.

Walk for Parkinson’s Walk with us on Moving Day, April 27, in Little Rock. Help fight Parkinson’s!

Gene Therapy Helps Reduce Medication and Ease Movement Symptoms in Phase I Study A study funded in part by The Michael J. Fox Foundation showed an investigational Parkinson's therapy helped reduce medication and led to more symptom control.

Researchers Have Identified a Gene Variant that Appears to Protect Against Alzheimer’s Forget the genes that cause it—let's hear about the genes that could stop it in its tracks!

New study for Parkinson's patients suffering with constipation 💩
PM for more details - or email [email protected]
>>>501.227.6179

We have several new studies for Parkinson's disease looking for volunteers. Call 501-227-6179 for more information or send a PM.

Happy Valentine's Day from all of us at Clinical Trials, Inc.!

Genentech said it was ending the CREAD 1 and CREAD 2 trials, designed to evaluate crenezumab in early Alzheimer’s.

“While the results with crenezumab are disappointing, they meaningfully contribute to our understanding of Alzheimer’s disease,” said Sandra J. Horning, MD, Genentech CMO and head of global product development.

Genentech's Crenezumab Fails Two Phase III Trials in Alzheimer's Genentech, a member of the Roche Group, said it will terminate two Phase III trials assessing its Alzheimer’s disease candidate crenezumab, adding to the list of candidates that have failed clinical studies in the memory-robbing ailment.